leisure time -WSS

leisure time

author：leisure time 2025-09-29 13:09:53 - browse：12

An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Head of FDA's diagnostics center, who led through Covid, retires

WSS

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

The best solution to the drug shortages problem

Friends ask where James Watson's attitudes about race came from

Wegovy’s successful heart trial raises vital question about weight loss

Cardiologists urge adding sexual orientation, gender identity to health records

leisure time

leisure time

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

HPV vaccine, cervical cancer study delivers historic results

FDA approval of Sarepta Duchenne genetic therapy gives me hope

HPV vaccine, cervical cancer study delivers historic results

Medical leaders decry Supreme Court decision on affirmative action

Maui's cultural, historic landmarks damaged in the devastating wildfires

Supreme Court strikes down use of affirmative action

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Sports medicine is finally prioritizing gender equality

Anavex keeps shifting the goalposts in its clinical trials

leisure time

Naloxone nonprofit donates 200,000 doses after FDA approval

Dana Farber says 6 studies to be retracted and 31 corrected

Inaction leaves children at risk from dangerous chemotherapy drug

Flu vaccine reformulation won't be easy, manufacturers warn

Cardiologists urge adding sexual orientation, gender identity to health records

Medicare drug price lawsuits could be good politics for Biden

knowledge

explore

hotspot

leisure time